Methanol extract of Muntingia calabura leaves attenuates CCl4-induced liver injury: possible synergistic action of flavonoids and volatile bioactive compounds on endogenous defence system
Context:Muntingia calabura L. (Muntingiaceae) exerts antioxidant and anti-inflammatory activities, thus, it might be a good hepatoprotective agent. Objective: This study investigates the effect of methanol extract of M. calabura leaves (MMCL) on hepatic antioxidant and anti-inflammatory activities i...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor and Francis Ltd
2019
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
LEADER | 05675nam a2201261Ia 4500 | ||
---|---|---|---|
001 | 10.1080-13880209.2019.1606836 | ||
008 | 220121s2019 CNT 000 0 und d | ||
020 | |a 13880209 (ISSN) | ||
245 | 1 | 0 | |a Methanol extract of Muntingia calabura leaves attenuates CCl4-induced liver injury: possible synergistic action of flavonoids and volatile bioactive compounds on endogenous defence system |
260 | 0 | |b Taylor and Francis Ltd |c 2019 | |
650 | 0 | 4 | |a acetylcysteine |
650 | 0 | 4 | |a adverse drug reaction |
650 | 0 | 4 | |a alanine aminotransferase |
650 | 0 | 4 | |a alanine aminotransferase blood level |
650 | 0 | 4 | |a animal |
650 | 0 | 4 | |a animal cell |
650 | 0 | 4 | |a animal experiment |
650 | 0 | 4 | |a animal model |
650 | 0 | 4 | |a animal tissue |
650 | 0 | 4 | |a Animals |
650 | 0 | 4 | |a antiinflammatory activity |
650 | 0 | 4 | |a antioxidant |
650 | 0 | 4 | |a antioxidant activity |
650 | 0 | 4 | |a Antioxidants |
650 | 0 | 4 | |a Article |
650 | 0 | 4 | |a aspartate aminotransferase |
650 | 0 | 4 | |a aspartate aminotransferase blood level |
650 | 0 | 4 | |a carbon tetrachloride |
650 | 0 | 4 | |a Carbon Tetrachloride |
650 | 0 | 4 | |a catalase |
650 | 0 | 4 | |a Chemical and Drug Induced Liver Injury |
650 | 0 | 4 | |a chemistry |
650 | 0 | 4 | |a controlled study |
650 | 0 | 4 | |a cytokine |
650 | 0 | 4 | |a dimethyl sulfoxide |
650 | 0 | 4 | |a dose response |
650 | 0 | 4 | |a Dose-Response Relationship, Drug |
650 | 0 | 4 | |a drug activity |
650 | 0 | 4 | |a drug dose comparison |
650 | 0 | 4 | |a drug potentiation |
650 | 0 | 4 | |a ermanin I |
650 | 0 | 4 | |a ermanin II |
650 | 0 | 4 | |a ferulic acid |
650 | 0 | 4 | |a flavonoid |
650 | 0 | 4 | |a Flavonoids |
650 | 0 | 4 | |a gallic acid |
650 | 0 | 4 | |a GCMS |
650 | 0 | 4 | |a genistein |
650 | 0 | 4 | |a hepatoprotective activity |
650 | 0 | 4 | |a herbal medicine |
650 | 0 | 4 | |a histopathology |
650 | 0 | 4 | |a interleukin 1beta |
650 | 0 | 4 | |a interleukin 6 |
650 | 0 | 4 | |a isolation and purification |
650 | 0 | 4 | |a kaempferide I |
650 | 0 | 4 | |a kaempferide II |
650 | 0 | 4 | |a liver enzyme |
650 | 0 | 4 | |a liver injury |
650 | 0 | 4 | |a liver level |
650 | 0 | 4 | |a liver protection |
650 | 0 | 4 | |a male |
650 | 0 | 4 | |a Male |
650 | 0 | 4 | |a Malvales |
650 | 0 | 4 | |a metabolism |
650 | 0 | 4 | |a methanol |
650 | 0 | 4 | |a Muntingia calabura |
650 | 0 | 4 | |a Muntingia calabura extract |
650 | 0 | 4 | |a Muntingiaceae |
650 | 0 | 4 | |a nitric oxide |
650 | 0 | 4 | |a nonhuman |
650 | 0 | 4 | |a oxidative stress markers |
650 | 0 | 4 | |a pathology |
650 | 0 | 4 | |a phenol derivative |
650 | 0 | 4 | |a phytochemical |
650 | 0 | 4 | |a Phytochemicals |
650 | 0 | 4 | |a phytochemistry |
650 | 0 | 4 | |a phytoconstituents |
650 | 0 | 4 | |a pinostrobin |
650 | 0 | 4 | |a plant extract |
650 | 0 | 4 | |a Plant Extracts |
650 | 0 | 4 | |a plant leaf |
650 | 0 | 4 | |a Plant Leaves |
650 | 0 | 4 | |a pro-inflammatory mediators |
650 | 0 | 4 | |a protein blood level |
650 | 0 | 4 | |a protocatechuic acid |
650 | 0 | 4 | |a qualitative analysis |
650 | 0 | 4 | |a quercetin |
650 | 0 | 4 | |a rat |
650 | 0 | 4 | |a Rats, Sprague-Dawley |
650 | 0 | 4 | |a Sprague Dawley rat |
650 | 0 | 4 | |a superoxide dismutase |
650 | 0 | 4 | |a toxic hepatitis |
650 | 0 | 4 | |a tumor necrosis factor |
650 | 0 | 4 | |a UHPLC-ESI |
650 | 0 | 4 | |a unclassified drug |
650 | 0 | 4 | |a unindexed drug |
650 | 0 | 4 | |a volatile organic compound |
650 | 0 | 4 | |a volatilization |
650 | 0 | 4 | |a Volatilization |
856 | |z View Fulltext in Publisher |u https://doi.org/10.1080/13880209.2019.1606836 | ||
856 | |z View in Scopus |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065763587&doi=10.1080%2f13880209.2019.1606836&partnerID=40&md5=98354bd208706f1095092acd99817931 | ||
520 | 3 | |a Context:Muntingia calabura L. (Muntingiaceae) exerts antioxidant and anti-inflammatory activities, thus, it might be a good hepatoprotective agent. Objective: This study investigates the effect of methanol extract of M. calabura leaves (MMCL) on hepatic antioxidant and anti-inflammatory activities in CCl4-induced hepatotoxic rat. Materials and methods: Sprague Dawley rats (n = 6) were treated (p.o.) with 10% DMSO (Groups 1 and 2), 50 mg/kg N-acetylcysteine (Group 3) or, 50, 250, or 500 mg/kg MMCL (Groups 4–6) for 7 consecutive days followed by pretreatment (i.p.) with vehicle (Group 1) or 50% CCl4 in olive oil (v/v) (Groups 2–6) on day 7th. Plasma liver enzymes and hepatic antioxidant enzymes and pro-inflammatory cytokines concentrations were measured while liver histopathology was examined. Results: MMCL, at 500 mg/kg, significantly (p < 0.05) ameliorated CCl4-induced hepatotoxicity by decreasing the plasma level of alanine transaminase (429.1 versus 168.7 U/L) and aspartate transaminase (513.8 versus 438.1 U/L) as well as the tissue level of nitric oxide (62.7 versus 24.1 nmol/g tissue). At 50, 250, or 500 mg/kg, MMCL significantly (p < 0.05) reduced the tumour necrosis factor α (87.8 versus 32.7 pg/mg tissue), interleukin-1β (1474.4 versus 618.3 pg/mg tissue), and interleukin-6 (136.7 versus 30.8 pg/mg tissue) while increased the liver catalase (92.1 versus 114.4 U/g tissue) and superoxide dismutase (3.4 versus 5.5 U/g tissue). Additionally, qualitative phytochemicals analysis showed that MMCL contained gallic acid, ferulic acid, quercetin, and genistein. Discussion and conclusions: MMCL ability to attenuate CCl4-induced hepatotoxicity could be helpful in the development of hepatoprotective agents with fewer side effects. © 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. | |
700 | 1 | 0 | |a Basir, R. |e author |
700 | 1 | 0 | |a Mahmood, N.D. |e author |
700 | 1 | 0 | |a Omar, M.H. |e author |
700 | 1 | 0 | |a Taher, M. |e author |
700 | 1 | 0 | |a Zakaria, Z.A. |e author |
773 | |t Pharmaceutical Biology |x 13880209 (ISSN) |g 57 1, 335-344 |